Establishment Labs (NASDAQ:ESTA) Trading Down 8.9% - Should You Sell?

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report)'s share price fell 8.9% during mid-day trading on Tuesday . The company traded as low as $28.50 and last traded at $28.51. Approximately 347,841 shares traded hands during mid-day trading, a decline of 20% from the average session volume of 433,839 shares. The stock had previously closed at $31.30.

Analysts Set New Price Targets

Separately, Stephens restated an "overweight" rating and set a $52.00 price objective on shares of Establishment Labs in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Establishment Labs Stock Performance

The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The firm's fifty day moving average price is $36.44 and its 200 day moving average price is $40.11. The firm has a market capitalization of $875.19 million, a PE ratio of -11.76 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. On average, research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Institutional Investors Weigh In On Establishment Labs

A number of large investors have recently bought and sold shares of ESTA. Quarry LP bought a new position in Establishment Labs in the 4th quarter valued at $27,000. R Squared Ltd bought a new position in Establishment Labs in the fourth quarter valued at about $36,000. KLP Kapitalforvaltning AS acquired a new stake in Establishment Labs in the fourth quarter worth about $161,000. Hood River Capital Management LLC raised its holdings in Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock worth $273,000 after purchasing an additional 4,160 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its position in Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after purchasing an additional 2,000 shares during the period. 72.91% of the stock is currently owned by institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.